Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Bri-Chem

OTCPK:BRYF.F
Snowflake Description

Adequate balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
BRYF.F
OTCPK
CA$3M
Market Cap
  1. Home
  2. US
  3. Capital Goods
Company description

Bri-Chem Corp. engages in the wholesale distribution of drilling fluid chemicals and blended drilling fluid to the oil and gas industry in North America. The last earnings update was 100 days ago. More info.


Add to Portfolio Compare Print
  • Bri-Chem has significant price volatility in the past 3 months.
BRYF.F Share Price and Events
7 Day Returns
-0.1%
OTCPK:BRYF.F
-0.6%
US Trade Distributors
0.5%
US Market
1 Year Returns
-30.2%
OTCPK:BRYF.F
10%
US Trade Distributors
20.3%
US Market
BRYF.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Bri-Chem (BRYF.F) -0.1% 6.8% 94% -30.2% -72.9% -91.5%
US Trade Distributors -0.6% -0.8% 1.2% 10% 16.4% 32%
US Market 0.5% 2% 9.4% 20.3% 40.4% 54.1%
1 Year Return vs Industry and Market
  • BRYF.F underperformed the Trade Distributors industry which returned 10% over the past year.
  • BRYF.F underperformed the Market in United States of America which returned 20.3% over the past year.
Price Volatility
BRYF.F
Industry
5yr Volatility vs Market

Value

 Is Bri-Chem undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Bri-Chem to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Bri-Chem.

OTCPK:BRYF.F Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 12.6%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:BRYF.F
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Trade Distributors Unlevered Beta Simply Wall St/ S&P Global 0.96
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.957 (1 + (1- 26.5%) (929.39%))
5.349
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (2 * 5.44%)
12.62%

Discounted Cash Flow Calculation for OTCPK:BRYF.F using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Bri-Chem is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

OTCPK:BRYF.F DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CAD, Millions) Source Present Value
Discounted (@ 12.62%)
2020 37.70 Est @ 82.48% 33.47
2021 59.66 Est @ 58.26% 47.04
2022 84.30 Est @ 41.3% 59.02
2023 109.12 Est @ 29.44% 67.83
2024 132.17 Est @ 21.13% 72.96
2025 152.41 Est @ 15.31% 74.70
2026 169.54 Est @ 11.24% 73.78
2027 183.76 Est @ 8.39% 71.01
2028 195.51 Est @ 6.39% 67.09
2029 205.28 Est @ 5% 62.55
Present value of next 10 years cash flows CA$629.00
OTCPK:BRYF.F DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= CA$205.28 × (1 + 1.74%) ÷ (12.62% – 1.74%)
CA$1,919.61
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CA$1,919.61 ÷ (1 + 12.62%)10
CA$584.87
OTCPK:BRYF.F Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CA$629.00 + CA$584.87
CA$1,213.87
Equity Value per Share
(CAD)
= Total value / Shares Outstanding
= CA$1,213.87 / 23.92
CA$50.74
OTCPK:BRYF.F Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in OTCPK:BRYF.F represents 0.7325x of TSX:BRY
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.7325x
Value per Share
(Listing Adjusted, USD)
= Value per Share (CAD) x Listing Adjustment Factor
= CA$ 50.74 x 0.7325
$37.17
Value per share (USD) From above. $37.17
Current discount Discount to share price of $0.09
= -1 x ($0.09 - $37.17) / $37.17
99.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Bri-Chem is available for.
Intrinsic value
>50%
Share price is $0.09 vs Future cash flow value of $37.17
Current Discount Checks
For Bri-Chem to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Bri-Chem's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Bri-Chem's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Bri-Chem's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Bri-Chem's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:BRYF.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CAD CA$-0.26
TSX:BRY Share Price ** TSX (2020-02-20) in CAD CA$0.12
United States of America Trade Distributors Industry PE Ratio Median Figure of 40 Publicly-Listed Trade Distributors Companies 16.56x
United States of America Market PE Ratio Median Figure of 2,894 Publicly-Listed Companies 18.35x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Bri-Chem.

OTCPK:BRYF.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:BRY Share Price ÷ EPS (both in CAD)

= 0.12 ÷ -0.26

-0.47x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Bri-Chem is loss making, we can't compare its value to the US Trade Distributors industry average.
  • Bri-Chem is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Bri-Chem's expected growth come at a high price?
Raw Data
OTCPK:BRYF.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.47x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Trade Distributors Industry PEG Ratio Median Figure of 33 Publicly-Listed Trade Distributors Companies 1.27x
United States of America Market PEG Ratio Median Figure of 1,996 Publicly-Listed Companies 1.61x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Bri-Chem, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Bri-Chem's assets?
Raw Data
OTCPK:BRYF.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CAD CA$0.81
TSX:BRY Share Price * TSX (2020-02-20) in CAD CA$0.12
United States of America Trade Distributors Industry PB Ratio Median Figure of 51 Publicly-Listed Trade Distributors Companies 1.7x
United States of America Market PB Ratio Median Figure of 5,103 Publicly-Listed Companies 1.79x
OTCPK:BRYF.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:BRY Share Price ÷ Book Value per Share (both in CAD)

= 0.12 ÷ 0.81

0.15x

* Primary Listing of Bri-Chem.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Bri-Chem is good value based on assets compared to the US Trade Distributors industry average.
X
Value checks
We assess Bri-Chem's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Trade Distributors industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Trade Distributors industry average (and greater than 0)? (1 check)
  5. Bri-Chem has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Bri-Chem expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bri-Chem has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.8%
Expected Trade Distributors industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Bri-Chem expected to grow at an attractive rate?
  • Unable to compare Bri-Chem's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Bri-Chem's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Bri-Chem's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:BRYF.F Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Trade Distributors Industry Earnings Growth Rate Market Cap Weighted Average 12.8%
United States of America Trade Distributors Industry Revenue Growth Rate Market Cap Weighted Average 4.4%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.2%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:BRYF.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:BRYF.F Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-09-30 98 21 -6
2019-06-30 107 14 -6
2019-03-31 112 12 -9
2018-12-31 121 2 -9
2018-09-30 122 -7 -3
2018-06-30 121 -13 -3
2018-03-31 118 -11 1
2017-12-31 116 -9 2
2017-09-30 110 -7 -1
2017-06-30 97 1 -3
2017-03-31 81 2 -4
2016-12-31 62 10 -7

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Bri-Chem is high growth as no earnings estimate data is available.
  • Unable to determine if Bri-Chem is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:BRYF.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Bri-Chem Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:BRYF.F Past Financials Data
Date (Data in CAD Millions) EPS *
2019-09-30 -0.26
2019-06-30 -0.25
2019-03-31 -0.37
2018-12-31 -0.39
2018-09-30 -0.14
2018-06-30 -0.11
2018-03-31 0.04
2017-12-31 0.07
2017-09-30 -0.05
2017-06-30 -0.12
2017-03-31 -0.17
2016-12-31 -0.29

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Bri-Chem will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Bri-Chem is trading at Bri-Chem'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Bri-Chem's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Capital Goods companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Bri-Chem's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Bri-Chem's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Bri-Chem has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Bri-Chem performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Bri-Chem's growth in the last year to its industry (Trade Distributors).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Bri-Chem does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Bri-Chem's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Bri-Chem's 1-year growth to the US Trade Distributors industry average as it is not currently profitable.
Earnings and Revenue History
Bri-Chem's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Bri-Chem Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:BRYF.F Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 98.12 -6.12 13.80
2019-06-30 107.48 -5.89 14.52
2019-03-31 112.02 -8.89 15.63
2018-12-31 121.44 -9.36 16.78
2018-09-30 121.65 -3.43 16.85
2018-06-30 121.03 -2.57 16.68
2018-03-31 117.54 0.92 15.88
2017-12-31 116.21 1.71 14.97
2017-09-30 110.39 -1.22 13.76
2017-06-30 96.85 -2.83 12.84
2017-03-31 81.26 -4.01 12.29
2016-12-31 62.09 -6.79 12.36
2016-09-30 61.50 -17.60 13.38
2016-06-30 72.00 -16.56 14.18
2016-03-31 85.43 -16.83 14.62
2015-12-31 96.82 -14.36 15.42
2015-09-30 125.61 -4.35 15.84
2015-06-30 151.39 -1.35 17.09
2015-03-31 164.97 -0.24 18.37
2014-12-31 184.71 1.11 18.34
2014-09-30 179.32 5.28 19.24
2014-06-30 169.36 3.86 18.34
2014-03-31 154.46 4.19 16.89
2013-12-31 150.04 4.27 16.18
2013-09-30 143.73 4.60 14.76
2013-06-30 137.32 4.34 14.64
2013-03-31 147.96 4.10 15.34

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Bri-Chem has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Bri-Chem has efficiently used its assets last year compared to the US Trade Distributors industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Bri-Chem improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Bri-Chem's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Trade Distributors industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Bri-Chem has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Bri-Chem's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Bri-Chem's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Bri-Chem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Bri-Chem's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Bri-Chem's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Bri-Chem Company Filings, last reported 4 months ago.

OTCPK:BRYF.F Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 19.32 24.59
2019-06-30 19.33 28.28
2019-03-31 20.36 34.52
2018-12-31 20.15 39.61
2018-09-30 25.30 41.53
2018-06-30 25.39 38.34
2018-03-31 28.96 41.58
2017-12-31 28.76 35.59
2017-09-30 28.70 29.79
2017-06-30 28.28 20.53
2017-03-31 29.00 26.98
2016-12-31 28.27 23.80
2016-09-30 30.90 20.22
2016-06-30 31.60 19.03
2016-03-31 33.10 26.30
2015-12-31 35.24 31.94
2015-09-30 44.00 41.10
2015-06-30 43.28 42.59
2015-03-31 44.34 52.17
2014-12-31 47.17 61.00
2014-09-30 51.40 51.91
2014-06-30 49.44 60.23
2014-03-31 51.47 71.25
2013-12-31 60.18 63.78
2013-09-30 53.57 66.23
2013-06-30 51.77 51.40
2013-03-31 53.40 63.10
  • Bri-Chem's level of debt (127.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (101.3% vs 127.3% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Bri-Chem has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Bri-Chem has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 1.5% per year.
X
Financial health checks
We assess Bri-Chem's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Bri-Chem has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Bri-Chem's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Bri-Chem dividends.
If you bought $2,000 of Bri-Chem shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Bri-Chem's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Bri-Chem's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:BRYF.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Trade Distributors Industry Average Dividend Yield Market Cap Weighted Average of 15 Stocks 2.7%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1961 Stocks 2.2%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Bri-Chem has not reported any payouts.
  • Unable to verify if Bri-Chem's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Bri-Chem's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Bri-Chem has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Bri-Chem's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Bri-Chem afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Bri-Chem has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Bri-Chem's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Don Caron
COMPENSATION CA$366,753
TENURE AS CEO 10.8 years
CEO Bio

Mr. Don Caron is a Partner at Western America Capital Group. Mr. Caron has been the Chief Executive Officer and President of Bri-Chem Corp since April 30, 2009. He served as Vice President of Western America Bancorp. Mr. Caron served as the Chief Executive Officer of Synergy Acquisition Corp. He served as the Secretary of Commercial Solutions, Inc. from 1993 to March 16, 2009. He has been the Chairman and Director of Bri-Chem Corp. since July 1997. Mr. Caron served as a Director of Salmon River Resources Ltd.; Synergy Acquisition Corp., from March 29, 2006 to October 10, 2013; Commercial Solutions, Inc., from 1993 to March 16, 2009 and MBase Commerce, Inc. He served as an Independent Director of Serenic Corp. from January 2000 to May 2010. He has extensive experience in operational management, public company compliance, financing and reorganization. He has advised and participated in several mergers and acquisition.

CEO Compensation
  • Don's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Don's remuneration is lower than average for companies of similar size in United States of America.
Management Team

Don Caron

TITLE
Chairman
COMPENSATION
CA$367K
TENURE
10.8 yrs

Jason Theiss

TITLE
Chief Financial Officer
COMPENSATION
CA$199K
TENURE
12.6 yrs
Board of Directors Tenure

Average tenure of the Bri-Chem board of directors in years:

13.4
Average Tenure
  • The average tenure for the Bri-Chem board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Don Caron

TITLE
Chairman
COMPENSATION
CA$367K
TENURE
22.6 yrs

Eric Sauze

TITLE
Independent Director
COMPENSATION
CA$53K
TENURE
13.1 yrs

Brian Campbell

TITLE
Independent Director
COMPENSATION
CA$38K
AGE
63
TENURE
13.1 yrs

Albert Sharp

TITLE
Independent Director
COMPENSATION
CA$41K
TENURE
13.7 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Bri-Chem individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
14. Feb 20 Buy Don Caron Individual 07. Feb 20 07. Feb 20 25,000 $0.10 $2,442
14. Feb 20 Buy Don Caron Individual 05. Feb 20 12. Feb 20 93,000 $0.10 $9,102
05. Feb 20 Buy Don Caron Individual 28. Jan 20 04. Feb 20 122,500 $0.10 $12,059
X
Management checks
We assess Bri-Chem's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Bri-Chem has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Bri-Chem Corp. engages in the wholesale distribution of drilling fluid chemicals and blended drilling fluid to the oil and gas industry in North America. It operates through five segments: Fluids Distribution Canada, Fluids Distribution USA, Fluids Blending & Packaging Canada, Fluids Blending & Packaging USA, and Other. The company supplies, blends, and packages drilling fluid products in various weights and clays, lost circulation materials, chemicals, and oil mud products. It also offers completion, cementing, acidizing, stimulation, and production chemical fluids; and sells calcium nitrate, silica fume, hydrated lime, potash, calcium carbonate, surfactants, and soda ash. In addition, the company provides testing of drilling fluids for customers for various analyses, including viscosity, fluid loss, lubricity, and others. Further, it provides various services to the oil and gas, industrial, agriculture, construction, and resource industries; and blends cementing additives, as well as holds truck and trailers. The company was founded in 1985 and is headquartered in Acheson, Canada.

Details
Name: Bri-Chem Corp.
BRYF.F
Exchange: OTCPK
Founded: 1985
CA$2,164,804
23,923,981
Website: http://www.brichem.com
Address: Bri-Chem Corp.
27075 Acheson Road,
Acheson,
Alberta, T7X 6B1,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX BRY Common Shares The Toronto Stock Exchange CA CAD 11. Jan 2007
OTCPK BRYF.F Common Shares Pink Sheets LLC US USD 11. Jan 2007
Number of employees
Current staff
Staff numbers
72
Bri-Chem employees.
Industry
Trading Companies and Distributors
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/02/21 01:58
End of day share price update: 2020/02/20 00:00
Last earnings filing: 2019/11/13
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.